Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04832685
NA

Neuromodulation of Mind-Wandering in Depression

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

The specific aim of this proposed study is to investigate the feasibility and therapeutic potential of LIFUP in changing negative cognition in depression. Specifically, the investigators will study if modulating DMN activity can change maladaptive mind-wandering. The investigators hypothesize that DOWN-modulation of the posterior cingulate cortex (PCC), a key DMN node, will decrease DMN resting state functional connectivity, perfusion, and activation during a cognitive-affective task (description below). The investigators also hypothesize that DOWN-modulation of the PCC will be associated with decreased mind-wandering and increased mindfulness. Finally, the investigators hypothesize that the opposite will be true for UP-modulation of the PCC.

Key Details

Gender

All

Age Range

18 Years - 64 Years

Study Type

INTERVENTIONAL

Enrollment

80

Start Date

2023-03-20

Completion Date

2026-12

Last Updated

2026-05-06

Healthy Volunteers

Yes

Conditions

Interventions

DEVICE

BrainSonix Pulsar 1002

Device that delivers low intensity focused ultrasound

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States